Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Galera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:08 pm Sale | 2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Venrock Healthcare Capital Partners III, L.P. | 917,860 3.700% | -825,528 (-47.35%) | Filing |
| 2020-11-04 4:52 pm Purchase | 2020-10-16 | 13G | Galera Therapeutics, Inc. GRTX | Venrock Healthcare Capital Partners III, L.P. | 1,743,388 7.000% | 1,743,388 (New Position) | Filing |